Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis

Glucagon-like Peptide-1 receptor agonists (GLP1-ra) are a relatively new class of anti-hyperglycemic drugs which may positively affect bone metabolism and thereby decrease (osteoporotic) bone fracture risk. Data on the effect of GLP1-ra on fracture risk are scarce and limited to clinical trial data...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Calcif Tissue Int
Hauptverfasser: Driessen, Johanna H. M., Henry, Ronald M. A., van Onzenoort, Hein A. W., Lalmohamed, Arief, Burden, Andrea M., Prieto-Alhambra, Daniel, Neef, Cees, Leufkens, Hubert G. M., de Vries, Frank
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer US 2015
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491344/
https://ncbi.nlm.nih.gov/pubmed/25894068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-015-9993-5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge